Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Insights from non-healthcare marketing: Brand Activism – does it have a role in Pharma?

Increasingly consumers are demanding that brands be more active – that they not only stand for something, but they do something about it.

Bedrock Healthcare Communications

- PMLiVE

Publication planning excellence at Porterhouse Medical

Porterhouse Medical Group is delighted to congratulate Emma Conran, Senior Medical Writer, on passing her ISMPP Certification Exam and becoming a Certified Medical Publication Professional (CMPP).This qualification comes from the...

Porterhouse Medical Group

- PMLiVE

AbbVie sells $30bn of bonds ahead of Allergan merger

Will use net proceeds to fund cash consideration due to shareholders

- PMLiVE

Syneos Health announces partnership with AiCure

Will leverage proprietary intelligent software and AI-driven insights

- PMLiVE

Election 2019: Labour tops Tory pledge on NHS spending

Pledge comes as campaigning for upcoming election gathers steam

- PMLiVE

Nucala works in rare inflammatory disease, says GSK

Company is planning to file for approval in indication next year

- PMLiVE

Solid Bio falls as FDA halts DMD trial over safety concerns

Shares in the biotech dropped dramatically following the announcement

The end of pharma

Some parts of our industry may go the way of the kitchen display cabinet and the word processor

- PMLiVE

ZPB Associates acquires PR specialist Journalista

Agencies have previously worked together on a number of campaigns

Bristol Myers Squibb logo

BMS scores FDA priority review for Opdivo/Yervoy combo in liver cancer

Possible new treatment for difficult to treat cancer type

- PMLiVE

Merck claims first-ever okay for Ebola vaccine, in Europe

Comes shortly after J&J filed its Ebola candidate with EMA

- PMLiVE

UK biotech Evgen craters on failed stroke trial

Shares in the biotech more than halved following the news

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links